Department of Pediatrics, University of Pittsburgh School of Medicine; UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
JAMA Netw Open. 2019 Aug 2;2(8):e199812. doi: 10.1001/jamanetworkopen.2019.9812.
A high Pao2, termed hyperoxemia, is postulated to have deleterious health outcomes. To date, the association between hyperoxemia during the ongoing management of critical illness and mortality has been incompletely evaluated in children.
To examine whether severe hyperoxemia events are associated with mortality among patients admitted to a pediatric intensive care unit (PICU).
DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study was conducted over a 10-year period (January 1, 2009, to December 31, 2018); all 23 719 PICU encounters at a quaternary children's hospital with a documented arterial blood gas measurement were evaluated.
Severe hyperoxemia, defined as Pao2 level greater than or equal to 300 mm Hg (40 kPa).
The highest Pao2 values during hospitalization were dichotomized according to the definition of severe hyperoxemia and assessed for association with in-hospital mortality using logistic regression models incorporating a calibrated measure of multiple organ dysfunction, extracorporeal life support, and the total number of arterial blood gas measurements obtained during an encounter.
Of 23 719 PICU encounters during the inclusion period, 6250 patients (13 422 [56.6%] boys; mean [SD] age, 7.5 [6.6] years) had at least 1 measured Pao2 value. Severe hyperoxemia was independently associated with in-hospital mortality (adjusted odds ratio [aOR], 1.78; 95% CI, 1.36-2.33; P < .001). Increasing odds of in-hospital mortality were observed with 1 (aOR, 1.47; 95% CI, 1.05-2.08; P = .03), 2 (aOR, 2.01; 95% CI, 1.27-3.18; P = .002), and 3 or more (aOR, 2.53; 95% CI, 1.62-3.94; P < .001) severely hyperoxemic Pao2 values obtained greater than or equal to 3 hours apart from one another compared with encounters without hyperoxemia. A sensitivity analysis examining the hypothetical outcomes of residual confounding indicated that an unmeasured binary confounder with an aOR of 2 would have to be present in 37% of the encounters with severe hyperoxemia and 0% of the remaining cohort to fail to reject the null hypothesis (aOR of severe hyperoxemia, 1.31; 95% CI, 0.99-1.72).
Greater numbers of severe hyperoxemia events appeared to be associated with increased mortality in this large, diverse cohort of critically ill children, supporting a possible exposure-response association between severe hyperoxemia and outcome in this population. Although further prospective evaluation appears to be warranted, this study's findings suggest that guidelines for ongoing management of critically ill children should take into consideration the possible detrimental effects of severe hyperoxemia.
高 PaO2(高氧血症)被认为会对健康产生有害影响。迄今为止,在儿童中,危重疾病持续管理期间的严重高氧血症事件与死亡率之间的关联尚未得到充分评估。
研究在儿科重症监护病房(PICU)入院的患者中,严重高氧血症事件是否与死亡率相关。
设计、地点和参与者:这是一项回顾性队列研究,在 10 年期间(2009 年 1 月 1 日至 2018 年 12 月 31 日)进行;对一家四级儿童医院所有有记录的动脉血气测量值的 23719 例 PICU 就诊进行了评估。
严重高氧血症定义为 PaO2 水平大于或等于 300 mm Hg(40 kPa)。
住院期间的最高 PaO2 值根据严重高氧血症的定义进行分类,并使用包含校准的多器官功能障碍、体外生命支持和在就诊期间获得的动脉血气测量总数的逻辑回归模型评估与院内死亡率的相关性。
在纳入期间,23719 例 PICU 就诊中,有 6250 例患者(13422 例[56.6%]为男孩;平均[标准差]年龄为 7.5[6.6]岁)至少有 1 次 PaO2 测量值。严重高氧血症与院内死亡率独立相关(调整后比值比 [aOR],1.78;95%置信区间,1.36-2.33;P<0.001)。随着严重高氧血症 PaO2 值获得的时间间隔大于或等于 3 小时,每增加 1 次(aOR,1.47;95%置信区间,1.05-2.08;P=0.03)、2 次(aOR,2.01;95%置信区间,1.27-3.18;P=0.002)和 3 次或更多次(aOR,2.53;95%置信区间,1.62-3.94;P<0.001),观察到院内死亡率的几率增加。一项检查残余混杂影响的敏感性分析表明,在严重高氧血症的 37%就诊中存在一个调整后比值比为 2 的未测量二项混杂因素,而在剩余队列中为 0%,则无法拒绝无效假设(严重高氧血症的调整后比值比,1.31;95%置信区间,0.99-1.72)。
在这个大型、多样化的危重儿童队列中,严重高氧血症事件的数量似乎与死亡率的增加有关,这支持了严重高氧血症与该人群结局之间可能存在的暴露-反应关系。尽管似乎需要进一步的前瞻性评估,但本研究的结果表明,危重儿童持续管理指南应考虑严重高氧血症可能产生的有害影响。